A Phase I and pharmocokinetic study of exatecan mesylate administered as a protracted 21-day infusion in patients with advanced solid malignancies.

药代动力学 医学 毒性 中性粒细胞减少症 限制 喜树碱 药理学 最大耐受剂量 入射(几何) 化疗 内科学 胃肠病学 化学 工程类 有机化学 物理 光学 机械工程
作者
Mitchell Garrison,Lisa A. Hammond,Charles E. Geyer,Garry Schwartz,Anthony W. Tolcher,Leslie Smetzer,José A. Figueroa,Murray P. Ducharme,John Coyle,Chris H. Takimoto,Robert L. De Jager,Eric K. Rowinsky
出处
期刊:PubMed 卷期号:9 (7): 2527-37 被引量:7
链接
标识
摘要

The purpose of this study was to assess the feasibility of administering exatecan, a water-soluble, potent camptothecin analogue, as a protracted 21-day continuous i.v. infusion (CIVI). The study also sought to determine the maximum tolerated dose (MTD) of exatecan on a 21-day CIVI schedule, characterize its pharmacokinetic behavior, and seek preliminary evidence of anticancer activity.Exatecan dose-schedule development was performed in two stages using the modified Continual Reassessment Method and single patient cohorts. First, patients with advanced solid malignancies were treated with exatecan (0.15 mg/m(2)/day) as a CIVI for 5 days, and the duration of the CIVI was incrementally increased from 5 to 21 days. In the second stage of the study, the dose was incrementally increased to derive a tolerable dose of exatecan administered as 21-day CIVI. The MTD was defined for both minimally pretreated (MP) and heavily pretreated (HP) patients as the highest dose level at which the incidence of dose-limiting toxicity does not exceed 20%.Thirty-one patients were treated with 100 courses of exatecan at 6 dose-schedule levels. The incidence of the principal dose-limiting toxicities, neutropenia and thrombocytopenia, was unacceptably high at exatecan doses exceeding 0.15 mg/m(2)/day as a 21-day CIVI, which was determined to be the MTD for both MP and HP patients. The pharmacokinetics of exatecan were dose-proportional, and mean [coefficient of variation (percentage) steady-state concentration (plasma concentration at steady-state)] values ranged from 6.88 (80.6) to 19.41 (74.2) ng/ml at exatecan dose levels ranging from 0.15 to 0.30 mg/m(2)/day, which are similar to IC(50) values against human tumor cell lines treated for shorter periods. Mean pharamacokinetic parameters for total exatecan derived from a compartmental model included clearance and volume of distribution values of 1.39 (86.9) liters/h/m(2) and 39.66 (197.4) liters, respectively. Two HP patients with non-small cell lung and unknown primary carcinomas had partial responses, and objective evidence of anticancer activity and clinical benefit were noted in several other individuals.The administration of exatecan as a 21-day CIVI at doses as high as 0.15 mg/m(2)/day is safe and feasible for both MP and HP patients. The characteristics of the myelosuppressive effects of exatecan on this schedule, the paucity of severe nonhematological toxicities, and documented anticancer activity in several drug-refractory malignancies warrant further evaluation of the merits of administering exatecan by either a CIVI or alternate drug delivery systems to achieve protracted systemic exposure.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
11秒前
Pupil完成签到,获得积分10
11秒前
偏偏意气用事完成签到,获得积分10
12秒前
安安完成签到,获得积分10
16秒前
cttc完成签到,获得积分10
17秒前
Chnimike完成签到 ,获得积分10
17秒前
21秒前
红茸茸羊完成签到 ,获得积分10
21秒前
年轻千愁完成签到 ,获得积分10
23秒前
liu完成签到,获得积分10
24秒前
量子星尘发布了新的文献求助10
24秒前
Wanyeweiyu完成签到,获得积分10
26秒前
Fury完成签到 ,获得积分10
31秒前
风中幻梦完成签到,获得积分10
33秒前
bigpluto完成签到,获得积分10
34秒前
36秒前
是谁还没睡完成签到 ,获得积分10
37秒前
盘尼西林发布了新的文献求助10
41秒前
zzz完成签到 ,获得积分10
43秒前
dktrrrr完成签到,获得积分10
45秒前
科研通AI2S应助科研通管家采纳,获得10
45秒前
丘比特应助科研通管家采纳,获得20
45秒前
45秒前
ccc完成签到,获得积分10
50秒前
萧秋灵完成签到,获得积分10
51秒前
缓慢冥幽完成签到,获得积分10
51秒前
旺仔同学完成签到,获得积分10
1分钟前
吉以寒完成签到,获得积分10
1分钟前
科研老兵完成签到,获得积分10
1分钟前
量子星尘发布了新的文献求助10
1分钟前
fys131415完成签到 ,获得积分10
1分钟前
执着的忆雪完成签到 ,获得积分10
1分钟前
1分钟前
闵不悔完成签到,获得积分10
1分钟前
阳光火车完成签到 ,获得积分10
1分钟前
cc完成签到,获得积分10
1分钟前
合适的寄灵完成签到 ,获得积分10
1分钟前
量子星尘发布了新的文献求助10
1分钟前
科研通AI5应助cc采纳,获得10
1分钟前
铜泰妍完成签到 ,获得积分10
1分钟前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Handbook of Industrial Diamonds.Vol2 1100
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038066
求助须知:如何正确求助?哪些是违规求助? 3575779
关于积分的说明 11373801
捐赠科研通 3305584
什么是DOI,文献DOI怎么找? 1819239
邀请新用户注册赠送积分活动 892655
科研通“疑难数据库(出版商)”最低求助积分说明 815022